Total Payments
$2,381
2024 Payments
$1,111
Companies
22
Transactions
133
Medicare Patients
3,139
Medicare Billing
$248,811
Payment Breakdown by Category
Food & Beverage$2,376 (99.8%)
Education$5.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,376 | 132 | 99.8% |
| Education | $5.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $396.71 | 24 | $0 (2024) |
| ABBVIE INC. | $368.03 | 18 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $343.33 | 15 | $0 (2024) |
| Lilly USA, LLC | $243.73 | 18 | $0 (2024) |
| Abbott Laboratories | $179.05 | 8 | $0 (2024) |
| Insulet Corporation | $169.83 | 10 | $0 (2018) |
| PFIZER INC. | $148.23 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $113.44 | 7 | $0 (2024) |
| Novo Nordisk Inc | $54.24 | 3 | $0 (2019) |
| Tandem Diabetes Care, Inc. | $48.98 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,111 | 58 | Otsuka America Pharmaceutical, Inc. ($269.28) |
| 2023 | $489.03 | 26 | PFIZER INC. ($118.55) |
| 2022 | $103.53 | 6 | ABBVIE INC. ($72.54) |
| 2019 | $39.90 | 2 | Novo Nordisk Inc ($39.90) |
| 2018 | $101.85 | 6 | AstraZeneca Pharmaceuticals LP ($25.55) |
| 2017 | $535.75 | 35 | AstraZeneca Pharmaceuticals LP ($162.97) |
All Payment Transactions
133 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: VACCINES | ||||||
| 10/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Respiratory | ||||||
| 09/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: PSYCHIATRY | ||||||
| 08/26/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Endocrinology | ||||||
| 08/22/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: VACCINES | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Biological | ||||||
| 07/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: PSYCHIATRY | ||||||
| 07/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Diabetes Care | ||||||
| 07/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.27 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: NEUROSCIENCE | ||||||
| 07/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Respiratory | ||||||
| 06/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 147 | 298 | $5,072 | $3,035 |
| 2022 | 6 | 152 | 350 | $9,768 | $2,229 |
| 2021 | 16 | 1,505 | 2,223 | $204,903 | $136,271 |
| 2020 | 17 | 1,335 | 1,933 | $182,548 | $107,276 |
Total Patients
3,139
Total Services
4,804
Medicare Billing
$248,811
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 19 | 19 | $1,463 | $922.49 | 63.1% |
| 85610 | Blood test, clotting time | Office | 2023 | 20 | 144 | $864.00 | $604.80 | 70.0% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 40 | 47 | $1,175 | $555.75 | 47.3% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 13 | 13 | $780.00 | $482.40 | 61.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 29 | 35 | $590.00 | $333.20 | 56.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 26 | 40 | $200.00 | $136.40 | 68.2% |
| 85610 | Blood test, clotting time | Office | 2022 | 25 | 208 | $1,248 | $881.64 | 70.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 18 | 19 | $1,463 | $576.70 | 39.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 22 | 24 | $600.00 | $285.15 | 47.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 17 | 20 | $332.00 | $191.50 | 57.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 41 | 49 | $245.00 | $168.21 | 68.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 30 | $5,880 | $125.63 | 2.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 328 | 328 | $52,152 | $44,001 | 84.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 274 | 466 | $69,900 | $42,857 | 61.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 275 | 481 | $49,062 | $28,678 | 58.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 112 | 141 | $8,601 | $5,370 | 62.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 38 | 49 | $4,802 | $3,060 | 63.7% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 141 | 141 | $2,820 | $2,820 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 141 | 141 | $3,525 | $2,398 | 68.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 14 | 14 | $3,178 | $2,392 | 75.3% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 14 | 14 | $1,526 | $1,526 | 100.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 35 | 103 | $3,708 | $1,070 | 28.8% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 17 | 18 | $1,044 | $687.15 | 65.8% |
| 85610 | Blood test, clotting time | Office | 2021 | 24 | 159 | $2,385 | $682.11 | 28.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 18 | 18 | $378.00 | $305.93 | 80.9% |
About Dr. Karen Wright-Sheridan, MD
Dr. Karen Wright-Sheridan, MD is a Internal Medicine healthcare provider based in Lexington, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588686315.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karen Wright-Sheridan, MD has received a total of $2,381 in payments from pharmaceutical and medical device companies, with $1,111 received in 2024. These payments were reported across 133 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,376).
As a Medicare-enrolled provider, Wright-Sheridan has provided services to 3,139 Medicare beneficiaries, totaling 4,804 services with total Medicare billing of $248,811. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Lexington, VA
- Active Since 07/24/2006
- Last Updated 05/10/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1588686315
Products in Payments
- REXULTI (Drug) $244.23
- FARXIGA (Drug) $236.06
- Omnipod (Device) $169.83
- QULIPTA (Drug) $155.44
- BREZTRI (Drug) $143.04
- VRAYLAR (Drug) $140.05
- MOUNJARO (Drug) $138.26
- FREESTYLE LIBRE 3 (Device) $134.25
- ABILIFY MAINTENA (Drug) $114.74
- SHINGRIX (Biological) $95.98
- NURTEC ODT (Drug) $95.38
- UBRELVY (Drug) $72.54
- FORTEO (Drug) $62.49
- t-slim insulin pump (Device) $48.98
- Veozah (Drug) $48.76
- FREESTYLE LIBRE 2 (Device) $44.80
- Ozempic (Drug) $35.25
- PAXLOVID (Drug) $32.87
- ELIQUIS (Drug) $30.34
- RECORLEV (Drug) $24.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lexington
Dr. Firas Badin, M.d, M.D
Internal Medicine — Payments: $1.9M
Internal Medicine $1.9M
Dennis Doherty, Md, MD
Internal Medicine — Payments: $686,622
Internal Medicine $686,622
Dr. Robert Sawyer, M.d, M.D
Internal Medicine — Payments: $232,104
Internal Medicine $232,104
David Mannino, Md, MD
Internal Medicine — Payments: $140,029
Internal Medicine $140,029
Dr. Anastasia Jandes, Md, MD
Internal Medicine — Payments: $90,742
Internal Medicine $90,742
Gloria Vigliani, M.d, M.D
Internal Medicine — Payments: $89,452
Internal Medicine $89,452